Press release
Lupus Nephritis Market Size Forecasted To Achieve 2.8 Billion By 2029 With Steady Growth
Lupus Nephritis
What Is the Lupus Nephritis Market Size and Projected Growth Rate?
The market for lupus nephritis has seen robust expansion in the past few years. The market, which is projected to escalate from $1.94 billion in 2024 to $2.09 billion in 2025, will have a compound annual growth rate (CAGR) of 7.9%. This growth during the historic span can be attributed to several factors including escalating investment in lupus nephritis research, a surge in the occurrence of autoimmune diseases, increasing healthcare costs, higher acceptance of biologics, and the rising prevalence of telemedicine.
Expectations are high for the lupus nephritis market size, projected to see robust growth in the upcoming years. By 2029, it's predicted to reach $2.80 billion, with a compound annual growth rate (CAGR) of 7.6%. Several factors contribute to this expected growth, including heightened awareness among physicians, a rise in the usage of biologic therapies, an increase in specialty clinics, accentuated significance of renal transplantation, and improved access to nephrology services. Key trends for the forecast period are enhancements in biologic therapies, personalized treatment strategies, innovative diagnostic biomarkers, expanded clinical trials, and advances in stem cell therapy.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22044
What Are the Major Segments in the Lupus Nephritis Market?
The lupus nephritis market covered in this report is segmented -
1) By Stage: Class 1, Class 2, Class 3, Other Stages
2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs
3) Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis.
2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition.
3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation.
4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp
What Are The Driving Lupus Nephritis Market Evolution?
The surge in genetic predisposition is anticipated to fuel the expansion of the lupus nephritis market in the future. Genetic predisposition pertains to the genetically inherited traits within an individual, heightening their probability of being afflicted by certain diseases or conditions. This growing prevalence is attributed to factors such as heredity, environmental influences, and alterations in specific genes. This increase in genetic predisposition plays an indispensable role in the onset of lupus nephritis, highlighting the effect of inherited genetic elements in autoimmune diseases, particularly those targetting kidney functionality. For example, in October 2024, as reported by the Cystic Fibrosis Trust, a charity based in the UK, the UK CF Registry reported 11,148 registered patients in 2022, which escalated to 11,318 in 2024, representing a 1.52% increase in individuals diagnosed with cystic fibrosis (CF). Consequently, the escalating prevalence of genetic predisposition is propelling the growth of the lupus nephritis market.
Which Firms Dominate The Lupus Nephritis Market Segments?
Major companies operating in the lupus nephritis market are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Genentech, Astrazeneca PLC, Biocon Biologics, Hanmi Pharmaceutical Co. Ltd., Sana Biotechnology Inc., RemeGen Co. Ltd., Aurinia Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Equillium Inc., Anthera Pharmaceuticals Inc., Atara Biotherapeutics Inc., Artiva Biotherapeutics, Caribou Biosciences, Nkarta Inc., Adicet Bio Inc., Lupus Research Alliance, Kyverna Therapeutics Inc., Kezar Life Sciences, Bionxt Solutions.
What Trends Are Expected to Dominate the Lupus Nephritis Market in the Next 5 Years?
Leading firms in the lupus nephritis market are concentrating on the advancement of second-generation calcineurin inhibitors to amplify the efficacy of treatments and promote better long-term kidney results for patients. These inhibitors play a crucial role in lupus nephritis by modulating immune responses to reduce inflammation and avoid kidney damage. For example, in September 2024, the Japanese Ministry of Health, Labour, and Welfare granted approval to Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company based in Canada, for the use of LUPKYNIS (voclosporin) in lupus nephritis treatment. The endorsement for voclosporin, allowing its use together with mycophenolate mofetil (MMF), was facilitated by positive data from the AURORA Clinical Program indicating its safety and effectiveness. This approval is a noteworthy step towards expanding treatment possibilities for lupus nephritis patients in Japan, thus making strides in disease management and results.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report
Which Is The Largest Region In The Lupus Nephritis Market?
Asia-Pacific was the largest region in the lupus nephritis market in 2024. The regions covered in the lupus nephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Lupus Nephritis Market?
2. What is the CAGR expected in the Lupus Nephritis Market?
3. What Are the Key Innovations Transforming the Lupus Nephritis Industry?
4. Which Region Is Leading the Lupus Nephritis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Nephritis Market Size Forecasted To Achieve 2.8 Billion By 2029 With Steady Growth here
News-ID: 4073313 • Views: …
More Releases from The Business Research Company
Top Market Shifts Transforming the Quantum-Enhanced Predictive Genomics Market L …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Quantum-Enhanced Predictive Genomics Market Through 2025?
The market size for quantum-enhanced predictive genomics has experienced rapid expansion in the past few years. The market is projected to increase from $1.45 billion in 2024 to $1.95 billion in 2025, displaying a compound annual…
Increasing Demand For Minimally Invasive Aesthetic Procedures Fueling The Growth …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Poly-L-Lactic Acid (PLA) Thread Lift Market Through 2025?
In recent times, the market size of the poly-L-lactic acid (PLA) thread lift has expanded exponentially. This market is projected to increase from $1.28 billion in 2024 to $1.49 billion in 2025, with a…
2025-2034 Pharmerging Market Evolution: Disruptions, Innovations, and Untapped O …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pharmerging Market Through 2025?
The size of the pharmerging market has expanded significantly over the past few years. Its projected growth is slated to rise from $2042.23 billion in 2024 to $2259.20 billion in 2025, with a compound annual growth rate (CAGR)…
Soaring Demand Set to Propel Personalized Gene Therapy Treatment Market to $17.6 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Personalized Gene Therapy Treatment Market Through 2025?
In recent times, there has been substantial growth in the market size of personalized gene therapy treatment. Predictions suggest that the market will expand from a worth of $6.93 billion in 2024 to $8.38 billion…
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
